Fri, Aug 22, 2014, 1:14 AM EDT - U.S. Markets open in 8 hrs 16 mins

Recent

% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

envy_vo 98 posts  |  Last Activity: Aug 14, 2014 10:53 AM Member since: Jul 13, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Positive spin, anyone?

    by imnorockefeller Aug 14, 2014 10:25 AM
    envy_vo envy_vo Aug 14, 2014 10:53 AM Flag

    Rocky,

    Have the reasons for your initial investment changed? If so, please tell us which of those reasons has changed.

    GLTU

    Sentiment: Strong Buy

  • Reply to

    One of the best money grabs I have seen .

    by bluehawaii100 Aug 14, 2014 10:27 AM
    envy_vo envy_vo Aug 14, 2014 10:47 AM Flag

    Blue,

    You do not seem to understand the dynamic:

    Frank is losing his shirt. He is selling shares daily and making less and less every day.

    The company, on the other hand, has cash to see them into 2016.

    I am thinking new management is ROTFLTAO at how much money Frank is losing. He should have found a private placement for his shares, when he had the chance.

    No luck for you!

    Sentiment: Strong Buy

  • Some people here seem to be unable to disassociate the price of the stock from the company and its potential.
    If you do not know why the price is going down and do not understand the prospects for the company, then I would think you would have already sold all of your shares. Unless, of course, you know nothing about investing and are just gambling. Gamblers are fine until they start whining.

    If you believe the company is in better shape than ever (I do), that the first-in-human clinical study will be successful (I do), and understand why the price is currently going down, then all you see (day after day) is an increasing opportunity to make terrific returns on your investment.

    The old adage "Buy low and sell high," seems simple enough, but there obviously must be more to it than that - and there is. That is why everyone cannot do it - it is just too hard to find a stock that is undervalued. Even if someone is lucky enough to find an undervalued stock, they have to be able to see why it is undervalued, or they will quickly lose confidence, become stressed, and sell low. Yes, they buy high and sell low. Everyone here who is worried about this stock and decides to sell is going to be someone who bought high and sold low. That is not how one makes money in the market.

    I have been adding shares all along. Typically, I buy at the end or beginning of the month, but today I just could not resist adding more shares. Do I hope the stock keeps going down? Yes, because every cent lower is a better opportunity. How hard would it be for this stock to hit $7 and that's a ten-bagger.

    I understand that, at some level, we are all gamblers; but when the dice run cold, please don't blame the other players. It is, after all, your money - manage it.

    Nobody owns enough NVIV, but please do not let my sentiment keep you from selling your shares or cause you to buy more.

    GLTA

    Sentiment: Strong Buy

  • I will be travelling for quite some time. I see no layovers that would be long enough for me to take advantage of a posting spate,

    I will be back on line around Monday, but that does not mean I will be posting then.

    Suffice it to say, nobody owns enough NVIV, but don't let my sentiment stop you from selling.

    GLTA

    Sentiment: Strong Buy

  • envy_vo envy_vo Aug 1, 2014 3:19 AM Flag

    Frank has less than 9 million shares,

    Now, maybe it all starts to make sense.

    Nobody owns enough NVIV, but please don't let my sentiment stop you from selling.

    GLTA

    Sentiment: Strong Buy

  • Reply to

    Shareholder Meeting Notes

    by factman777 Jul 31, 2014 12:38 AM
    envy_vo envy_vo Jul 31, 2014 6:53 PM Flag

    Thanks for the update. I certainly was interested and thought you did a great job of reporting.

    GLTU

    Sentiment: Strong Buy

  • Everything coming out of the meeting seems upbeat.

    The company has everything moving in a good and focused direction.

    Somebody has been buying a lot of shares.

    Let's speculate for a moment that it was JNap buying those shares. If he came out with a very, very strong piece on NVIV, where do you think the stock would go? He could easily say "This could be the easiest double in our lifetime."

    If I were him, I would be loading up here and then, when they enroll their first patient, I would come out with the Strong Buy article.

    Given the number of shares being bought and the fact that JNAP is, apparently, tweeting about NVIV, it looks to me like this is already in the works.

    He might even quote me in his upcoming SeekingAlpha article - you know:

    "Nobody owns enough NVIV."

    You heard it here first! BTW, please don't let my sentiment stop you from selling your shares.

    GLTA

    Sentiment: Strong Buy

  • Reply to

    A look at the numbers

    by envy_vo Jul 31, 2014 2:55 PM
    envy_vo envy_vo Jul 31, 2014 5:31 PM Flag

    Goober, goober, goober,

    Dishonest and ignorant have not served you well here. Dumb is clearly not going to help your lack of credibility.

    You said, "A penetrating injury is a wound generally caused by a gun, knife, arrow, etc. There is no relationship between the area of the wound and whether it is a penetrating injury."

    Well, of course there is. Given, as YOU SAID, the rib cage protects the thoracic region, and a penetrating injury is generally cause by a knife, etc. If you had a penetrating injury, where would it most likely occur?

    a. neck (cervical region)
    b. trunk (thoracic region)
    c. your #$%$ (vocal region)

    Dishonest, ignorant, and dumb is no way to go through life.

    No luck for you!

    Sentiment: Strong Buy

  • Reply to

    A look at the numbers

    by envy_vo Jul 31, 2014 2:55 PM
    envy_vo envy_vo Jul 31, 2014 5:17 PM Flag

    Goober?

    You did it again! "maybe you two should go back to creating a few more 'I was the shareholders meeting' aliases..."

    You have no way of knowing what I am doing. That is, you are ignorant of matters that concern me (except for what I post). Consequently, you are, once again, talking about something you know nothing about!

    That is why you have no credibility, and why some people probably give you a thumbs down without reading your dishonest/ignorant posts.

    Dishonest and ignorant is no way to go through life.

    No luck for you!

    Sentiment: Strong Buy

  • Reply to

    A look at the numbers

    by envy_vo Jul 31, 2014 2:55 PM
    envy_vo envy_vo Jul 31, 2014 4:52 PM Flag

    goober,

    I think people give you thumbs down all the time, because you lie so frequently. I think some people just do it without even reading your drivel. Who wants to read a liar?

    If you are going to lie to people on a message board, and post about things you know nothing about, then you have to expect the large number of "thumbs down" you get.

    Dishonest and foolish is no way to go through life.

    No luck for you!

    Sentiment: Strong Buy

  • Reply to

    A look at the numbers

    by envy_vo Jul 31, 2014 2:55 PM
    envy_vo envy_vo Jul 31, 2014 4:45 PM Flag

    goober,

    You said my numbers are off; however, you can offer no refinement except to say that it would be less than the total ASIA-A, non-penetrating patients. The numbers I calculated (do to rounding) do reflect less patients than the total ASIA-A figure). You have no data to support your guess.

    So, yes, that would exclude cervical patients, but then they are not "protected by the rib cage" and are more likely to be "penetrating," all else being equal. The point is that you can provide no alternative to the numbers given, except to say that it should be less. That is, you have no real numbers to site, which leaves you impotent, as always.

    You said, "Add to that the fear and confusion about an experimental treatment in its first safety trial that will likely only allow the patient to gain two to three segmental levels of function at best, which to a thoracic level patient, does not mean very much as far as functionality. It is easy to see how even the bravest person would be skittish."

    Nothing but mumbo-jumbo -

    1. Two or three segments of function is huge to someone who does not have them.
    2. GERON enrolled patients that apparently believed there would be NO benefit. One said, specifically, that she enrolled to help move the science forward, while believing she would get no immediate benefit, herself.
    3. Your term "skittish" is meaningless - but hey, your mumbo-jumbo and lies are always meaningless.

    OTOH, I agree that 27 patients a quarter may be inflated; but if we drop it by 10%, it is still 24 patients a quarter or 8/month; even if we drop it by 33%, it is still 18 patients a quarter or 6/month. Even if we exclude 67% of all ASIA-A non-penetrating patients, it is still, at least, 3 patients a quarter (on average).

    My point, nevertheless, remains the same - I am glad the management is apparently waiting for the best first implementation of its scaffold.

    Nobody owns enough NVIV, but please do not let my sentiments stop you from selling.

    No luck for you!

    Sentiment: Strong Buy

  • According to InVivo’s Investor Presentation

    1. There are 202 Level I Trauma centers nationally.

    2. There are 3,750 ASIA-A spinal cord injuries/year (non-penetrating).

    3. That would be 18 cases/year at each center, 4.5/quarter, or 1.5/month, on average.

    4. InVivo has three centers ready for enrollment.

    5. On average, we can expect 4.5 patients to present for treatment every month or 13.5 patients every quarter. If InVivo can double the number of sites by the end of September, the number of patients/quarter would double to 27 (on average).

    Those are the numbers, as I see them (please correct me, if I have made a mistake).

    The fact that a patient has yet to be enrolled suggests the Principal Investigators are looking to maximize the possibility of benefit. That is, of the 3,750 patients that qualify, there will clearly be some individual variability in the nature of the injuries. That variability suggests some injuries would be more responsive to Scaffold implantation than others, or the surgery itself might be safer in some cases than others.

    I doubt there would be any definitive statistics available that would provide InVivo with a specific number of a particular subset of ASIA-A patients, who would benefit most or whose surgery would be safest. So, I would not think they would send out a PR stating the likelihood of enrolling a patient during a given interval. Of course, the patient would have to agree to participate (no idea if anyone would not participate, given they were facing permanent paralysis).

    Certainly, any worthwhile management group would be looking for the best initial implementation of their product, given so much rests on the outcome. Therefore, I see no reason to be upset because it appears it is taking some time to find the best initial patient. In fact, I am glad management is apparently looking for their best initial implementation of the scaffold.

    Nobody owns enough NVIV, but please don’t let my sentiment stop you from selling.

    GLTA

    Sentiment: Strong Buy

  • envy_vo by envy_vo Jul 29, 2014 3:46 PM Flag

    The pilot study is not a "take-what-you-get" type of enrollment. That is, the company gets to select the specific type of SCI they intend to treat. Given the requirement for HUD of less than 4000 patients (there are 10,000 SCIs a year), it would seem to me the company could limit their very, very small Pilot Study to a very, very small segment of the acute SCI population. Given NVIV wants to show safety and probable benefit it makes a lot of sense to limit the SCI of the five patients to the least severe injuries they can find that would still benefit from the use of a scaffold. At least, they could move along a dimension of severity of injury from less to more as they enroll more and more patients.

    For example, they could conceivably limit their intention to treat to those patients who would develop Brown-Sequard Syndrome. I believe that is the type of SCI they used on the Monkeys. If so, I would expect a very good prognosis - something very dramatic. Given humans are going to rehab better than moneys, I would certainly expect Humans, with this type of injury, Walking. Further, they could limit their patient population to those who are even less injured than those with Brown-Sequard. Good rehab should show remarkable results.

    So, a little delay in enrolling patients should come as no surprise. Let's all hope the first trial is intelligently planned to show remarkable success, given safety is virtually assured. I think this is what the company was referring to, when it said it hoped for a long stream of great PRs - continued remarkable success.

    Nobody owns enough NVIV, but please don't let my sentiment stop you from selling.

    GLTA

    Sentiment: Strong Buy

  • Reply to

    Looking for good news?

    by envy_vo Jul 29, 2014 2:26 AM
    envy_vo envy_vo Jul 29, 2014 2:36 PM Flag

    There are many dishonest posters on this message board (to be expected, I guess). One of them, misanthrope, said the following:

    "Nobody saw a "scaffold only" monkey walking and nobody saw a "scaffold only" monkey climbing a ladder."

    This is from the web site presentation that was removed. Many of us saw the video.

    "R090 Scaffold No Drugs/No Cells

    [Video shows AGM twelve weeks post injury (received the scaffold without drugs or cells after 50% of the tissue from a section of the spinal cord was removed). Wireless EMG and Kinematic technologies were added to the second study protocol to monitor electrical activity in the muscles in the legs of the animals. The animal runs on a treadmill demonstrating the left leg has regained function.] "

    Yes, the Monkey is running on a treadmill and only received the "scaffold without drugs or cells."

    As for a "scaffold only" Monkey climbing a ladder?

    "Scaffold Only: Climbing Test: Left foot toe control

    [The video shows an animal that received the InVivo treatment after injury climbing an A-frame ladder. The injured leg has regained function demonstrating intentional grasping of the rungs of the ladder with both feet.] "

    Note, the Climbing test was for a "Scaffold only" Monkey.

    No luck for you!

    Sentiment: Strong Buy

  • Reply to

    Level 2 Anyone?

    by amandak4mk Jul 29, 2014 2:03 PM
    envy_vo envy_vo Jul 29, 2014 2:21 PM Flag

    You're welcome!

    I just wanted to get you the answer as soon as I saw the question. More detail:

    5K bid at 0.97
    3K bid at $0.94
    50K bid at $0.936

    GLTU

    Sentiment: Strong Buy

  • Reply to

    Fallacious thinking?

    by envy_vo Jul 29, 2014 1:44 PM
    envy_vo envy_vo Jul 29, 2014 2:15 PM Flag

    Sissy,

    Looks like your going to have to go to "triple ignore," because you can obviously still see my posts.

    Do you really think anyone here believes your BS number of shares?

    No luck for you - and that's a bad thing!

    Sentiment: Strong Buy

  • Reply to

    Fallacious thinking?

    by envy_vo Jul 29, 2014 1:44 PM
    envy_vo envy_vo Jul 29, 2014 2:13 PM Flag

    Misanthrope,

    Please explain yourself?

    Sentiment: Strong Buy

  • Reply to

    Level 2 Anyone?

    by amandak4mk Jul 29, 2014 2:03 PM
    envy_vo envy_vo Jul 29, 2014 2:11 PM Flag

    Yes!

    Sentiment: Strong Buy

  • Reply to

    Not exactly Mass General...

    by imamisanthrope Jul 29, 2014 1:20 PM
    envy_vo envy_vo Jul 29, 2014 2:08 PM Flag

    Misanthrope,

    Yes, and Mass General hired this "goober:"

    An internationally renowned expert on eating disorders employed by Massachusetts General Hospital has resigned amid allegations of reported sexual misconduct.

    With this resignation, both physicians surrender their licenses to practice medicine, and they surrender any medical licenses to practice in any other state. Both Dr. Herzog and Dr. Porter will never seek licensure elsewhere.

    So, maybe you need to set the bar a little higher - goober!

    No luck for you!

    Sentiment: Strong Buy

  • Reply to

    Fallacious thinking?

    by envy_vo Jul 29, 2014 1:44 PM
    envy_vo envy_vo Jul 29, 2014 2:01 PM Flag

    Misanthrope,

    Why don't you post what you did earlier today on this thread?

    Sentiment: Strong Buy

NVIV
0.67-0.03(-4.67%)Aug 20 3:58 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.